Veterinary Healthcare Market Size
Global Veterinary Healthcare Market reached US$ 51.26 billion in 2025 and is expected to reach US$ 113.50 billion by 2033, growing with a CAGR of 10.37% during the forecast period 2026-2033.
Veterinary Healthcare includes veterinary services, animal medicine, and Veterinary Medical Equipment. Veterinary medicine can be defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals. The increasing importance of the production of Livestock Animals is generating growth in the veterinary healthcare market.
Key Takeaways -Veterinary Healthcare Market
US$113.50 billion is the 2033 market opportunity. The global veterinary healthcare market’s expansion from US$51.26 billion in 2025 reflects rising awareness of animal health, increasing livestock production, growing pet ownership and demand for veterinary services, medicines and diagnostics.
Asia-Pacific remains the fastest-growing region. North America holds the largest market share, while Asia-Pacific is the fastest-growing market, supported by increasing animal healthcare awareness, livestock production and veterinary healthcare development.
Therapeutics is becoming a key growth engine. Therapeutics is expected to grow at the highest CAGR during 2026–2033, supported by advances in vaccines, parasiticides, medicinal feed additives, nutritional feed additives and anti-infectives.
Companion animal healthcare is gaining strategic importance. Rising pet ownership, increased consumer awareness of pet health and growing demand for preventive and specialty veterinary services are supporting the companion animal segment.
Preventive care is reshaping veterinary demand. Regular check-ups, vaccination, early disease detection and increasing awareness of animal welfare are strengthening demand for routine and advanced veterinary healthcare services.
AI and digital diagnostics are emerging as technology catalysts. AI-driven diagnostic systems, cloud-based practice management and telehealth platforms are supporting digital transformation in veterinary clinics and improving diagnostic workflows.
Zoonotic disease prevention is a major market driver. The increasing incidence of zoonotic diseases, advances in animal healthcare diagnostics and government initiatives are creating demand for improved disease prevention and treatment solutions.
Veterinary hospitals and clinics remain core service channels. Veterinary hospitals, veterinary clinics and laboratory testing services form key end-user segments, supported by rising demand for animal diagnosis, treatment and preventive care.
Regulatory and affordability challenges are shaping market access. High veterinary service and animal testing costs, limited infrastructure, counterfeit medicines and restrictions on excessive antibiotic use remain important challenges for the global veterinary healthcare industry.
Product launches, partnerships and digital integration are influencing competition. Major veterinary healthcare companies are adopting product launches, mergers and acquisitions, partnerships and collaborations to expand market presence and develop new animal healthcare solutions.
Veterinary Healthcare Market Scope
| Metrics | Details |
| Market CAGR | 10.37% |
| Segments Covered | By Type, By Application, By End User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
Request Free Sample Click here
Veterinary Healthcare Market Dynamics
The global veterinary healthcare market is growing due to several factors such as, increasing incidence of zoonotic diseases, rising awareness towards animal health, technological advancements in animal healthcare diagnostics and increasing government initiatives from the global veterinary medical association.
There are several groups and associations in different countries for the welfare of animals. For instance, in the UK, the Cattle Health and Welfare Group (CHAWG) addresses relevant cattle health and welfare issues and in the US, there are associations, such as Winter Haven, where the veterinary healthcare allies with the human-animal bond and provide high-quality services.
Growth in the pet population, increasing penetration of pet insurance, pet humanization within the growing global urban population, and increased awareness of animal welfare needs due to social media are helping the veterinary industry to maintain growth at 6.2% a year. Increased awareness of preventative care and the availability of specialty services have created a higher demand for both routine and more sophisticated procedures. Government and industry organizations have taken the lead in increasing awareness of the benefits of preventative care, highlighting the importance of keeping pets healthy with regular check-ups.
However, the high costs of veterinary services and animal testing, lack of infrastructure and funding, and use of counterfeit medicines are hindering the growth of the veterinary healthcare market globally. Also, restrictions imposed by regulatory bodies against the excessive use of antibiotics in animal production and protest of activists against animal research are hampering the market growth.
Veterinary Healthcare Market Segmentation
By product, the global veterinary healthcare market is segmented into therapeutics and diagnostics tools. Among these, therapeutics is growing at the highest CAGR during the forecast period 2026-2033. The therapeutics market is further segmented into vaccines, parasiticides, medicinal feed additives, nutritional feed additives, anti-infectives, and others. Recent advances in technologies and the improved understanding of pathogenicity, immunology, and epidemiology have opened new opportunities for preventing infectious diseases at an unprecedented level. Improved understanding of the immunogenic and protective antigens of pathogens, as well as the ability to produce recombinant proteins cost-effectively and at high quality, have opened the door to Subunit and virus-like particle (VLP)-based vaccines that are based on relevant antigens only, Live vaccines using targeted deletions and modifications and vector-based veterinary vaccines. New product launches and strategic partnerships are the key strategies adopted by healthcare companies to increase their share in the untapped global market.
By animal type, a companion animal is expected to hold a significant market share during the forecast period due to rising pet ownership along with increased consumer awareness of health issues affecting pets in developed countries. According to the American Pet Products Association, 68% of U.S. households have a pet. More than 60 million households have dogs, while 47 million have cats. Growing companion animal care expectations and demands also play an important role in the development and growth of the companion animal healthcare market.
Veterinary Healthcare Market Major Players
The Veterinary Healthcare market is highly competitive with the presence of a large number of players. Some of the major players in the global veterinary healthcare market are MSD animal health, Novartis International AG, Bayer Healthcare, Cargill Inc., Merck Ltd., Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Zoetis Animal Healthcare, Elanco Animal Health, and Phibro Animal Health.
The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Veterinary Healthcare market globally.
Veterinary Healthcare Market Recent Developments
July 2026 – Merck Animal Health expands feline vaccination protection in Europe Merck Animal Health received European Commission marketing authorization for NOBIVAC NXT HCPChFeLV, strengthening its companion animal vaccine portfolio and supporting preventive healthcare for cats.
July 2026 – Zoetis advances veterinary diagnostics through teleradiology acquisition Zoetis completed the acquisition of VitalRADS, a veterinary teleradiology services platform, expanding its Global Diagnostics business with cloud-based access to board-certified veterinary specialists and imaging interpretation capabilities.
June 2026 – Merck Animal Health strengthens livestock disease prevention Merck Animal Health announced the acquisition of TARGAN and reinforced its commitment to protecting U.S. livestock from the New World screwworm threat, highlighting continued investment in livestock health and disease-control solutions.
June 2026 – Merck Animal Health expands companion animal healthcare research Merck Animal Health released research highlighting challenges faced by dog owners and veterinarians in treating allergic skin disease, supporting the need for targeted, rapid-onset treatments for dogs of different age groups.
May 2026 – Elanco strengthens innovative pet and farm animal healthcare portfolio Elanco reported first-quarter revenue growth of 15% year-over-year to US$1.371 billion, supported by pet health and farm animal products. The company also highlighted Zenrelia’s blockbuster status and Credelio Quattro’s expanding veterinary clinic presence, reinforcing its focus on innovative animal health solutions.
May 2026 – Zoetis advances animal health innovation and diagnostics Zoetis reported first-quarter 2026 revenue of US$2.3 billion and highlighted a pipeline of more than 12 potential blockbuster candidates across chronic kidney disease, oncology, cardiology, anxiety, and obesity. The company continued expanding companion animal, livestock, and diagnostic solutions.
March 2026 – Merck Animal Health receives FDA approval for extended-duration canine tick protection The FDA approved BRAVECTO QUANTUM from Merck Animal Health for the treatment and control of Asian Longhorned Tick and Gulf Coast Tick for 12 months in dogs, expanding long-duration parasite protection options in veterinary healthcare.
February 2026 – Merck Animal Health launches NUMELVI for canine allergic dermatitis The FDA approved NUMELVI (atinvicitinib tablets), a second-generation Janus kinase inhibitor for dogs, to control pruritus associated with allergic dermatitis, strengthening treatment options for companion animal dermatology.
January 2026 – Elanco expands companion animal parasiticide and dermatology innovation Elanco continued commercial expansion of Credelio Quattro and Zenrelia, supporting broad-spectrum parasite protection and allergic dermatitis management in dogs while strengthening its innovative pet healthcare portfolio.
